National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.
Liaquat National hospital and Medical College, Karachi, Pakistan.
Glob Heart. 2024 Jun 26;19(1):53. doi: 10.5334/gh.1336. eCollection 2024.
The objective of this study is to conduct a temporal analysis of rheumatic heart disease (RHD) disease burden trends over a 30-year period (1991 to 2021), focusing on prevalence, deaths, and disability-adjusted life years (DALYs) in the South Asia (SA).
In this ecological study, we analyzed data regarding burden of RHD from the Global Burden of Diseases (GBD) study spanning the years 1991 to 2021 for the SA Region. Estimates of the number RHD-related prevalence, deaths, and DALYs along with age-standardized rates (ASR) per 100,000 population and 95% uncertainty intervals (UI) were evaluated.
The overall prevalent cases of RHD in the 2021 were 54785.1 × 10 (43328.4 × 10 to 67605.5 × 10), out of which 14378.8 × 10 (11206.9 × 10 to 18056.9 × 10) were from SA. The ASR of point prevalence showed upward trend between 1991 and 2021, at global level and for SA with an average annual percentage change (AAPC) of 0.40 (0.39 to 0.40) and 0.12 (0.11 to 0.13), respectively. The overall number of RHD-related deaths in the 2021 were 373.3 × 10 (324.1 × 10 to 444.8 × 10), out of which 215 × 10 (176.9 × 10 to 287.8 × 10) were from SA, representing 57.6% of the global deaths. The ASR of deaths also showed downward trend between 1991 and 2021, at global level and for SA with an AAPC of -2.66 (-2.70 to -2.63) and -2.07 (-2.14 to -2.00), respectively. The ASR of DALYs showed downward trend between 1990 and 2019, at global level and for South Asian region with an AAPC of -2.47 (-2.49 to -2.44) and -2.22 (-2.27 to -2.17), respectively.
The rising age-standardized prevalence of RHD remains a global concern, especially in South Asia which contribute to over 50% of global RHD-related deaths. Encouragingly, declining trends in RHD-related deaths and DALYs hint at progress in RHD management and treatment on both a global and regional scale.
本研究旨在对风湿性心脏病(RHD)疾病负担趋势进行 30 年的时间分析(1991 年至 2021 年),重点关注南亚(SA)的患病率、死亡人数和伤残调整生命年(DALY)。
在这项生态学研究中,我们分析了 1991 年至 2021 年全球疾病负担(GBD)研究中与 RHD 相关的负担数据,涉及南亚地区。评估了 RHD 相关的患病率、死亡人数和 DALY 的数量,以及每 10 万人的年龄标准化率(ASR)和 95%的置信区间(UI)。
2021 年全球 RHD 的总流行病例为 54785.1×10(43328.4×10 至 67605.5×10),其中 14378.8×10(11206.9×10 至 18056.9×10)来自 SA。1991 年至 2021 年,全球和 SA 的点患病率 ASR 呈上升趋势,平均年变化百分比(AAPC)分别为 0.40(0.39 至 0.40)和 0.12(0.11 至 0.13)。2021 年全球 RHD 相关死亡人数为 373.3×10(324.1×10 至 444.8×10),其中 215×10(176.9×10 至 287.8×10)来自 SA,占全球死亡人数的 57.6%。1991 年至 2021 年,全球和 SA 的死亡率 ASR 也呈下降趋势,AAPC 分别为-2.66(-2.70 至-2.63)和-2.07(-2.14 至-2.00)。1990 年至 2019 年,全球和南亚地区的 DALY ASR 呈下降趋势,AAPC 分别为-2.47(-2.49 至-2.44)和-2.22(-2.27 至-2.17)。
风湿性心脏病的年龄标准化患病率呈上升趋势,这仍是一个全球性问题,尤其是在南亚,该地区占全球与 RHD 相关死亡人数的 50%以上。令人鼓舞的是,RHD 相关死亡人数和 DALY 的下降趋势表明,在全球和区域范围内,RHD 的管理和治疗都取得了进展。